HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erik Martens Selected Research

oxyamylose (COAM)

1/2014Interference with glycosaminoglycan-chemokine interactions with a probe to alter leukocyte recruitment and inflammation in vivo.
8/2012Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function.
11/2010Myeloid cells are tunable by a polyanionic polysaccharide derivative and co-determine host rescue from lethal virus infection.
10/2008Virus entry inhibition by chlorite-oxidized oxyamylose versus induction of antiviral interferon by poly(I:C).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erik Martens Research Topics

Disease

11Inflammation (Inflammations)
01/2020 - 06/2003
7Neoplasms (Cancer)
05/2020 - 09/2008
5Autoimmune Diseases (Autoimmune Disease)
01/2019 - 12/2004
4Rheumatoid Arthritis
01/2021 - 12/2004
4Necrosis
02/2020 - 12/2004
4Multiple Sclerosis
01/2018 - 06/2003
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019 - 05/2011
3Chronic Pancreatitis
01/2016 - 05/2003
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 06/2003
2Fibrosis (Cirrhosis)
11/2016 - 12/2012
2Diabetic Retinopathy (Retinopathy, Diabetic)
11/2014 - 08/2006
2Infections
11/2010 - 10/2008
2Virus Diseases (Viral Diseases)
11/2010 - 06/2003
2Cerebral Malaria
04/2008 - 02/2008
2Pancreatitis
12/2004 - 05/2003
1Hypersensitivity (Allergy)
10/2022
1Arthritis (Polyarthritis)
01/2021
1COVID-19
11/2020
1Ulcerative Colitis
02/2020
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2019
1Esophageal Achalasia (Megaesophagus)
11/2018
1Septic Shock (Toxic Shock Syndrome)
10/2017
1Endotoxemia
10/2017
1Disease Progression
01/2017
1Colitis
11/2016
1Crohn Disease (Crohn's Disease)
11/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1Autoimmune Pancreatitis
01/2016
1Adenocarcinoma
01/2016
1Diabetic Neuropathies (Diabetic Neuropathy)
11/2014
1Neuroinflammatory Diseases
10/2012
1Melanoma (Melanoma, Malignant)
08/2012
1Rupture
05/2012
1Brain Diseases (Brain Disorder)
05/2012
1Malaria
05/2012
1Autoimmune Lymphoproliferative Syndrome
05/2011
1Lymphadenopathy
05/2011
1Splenomegaly
05/2011
1Vascular Diseases (Vascular Disease)
02/2008
1Hematologic Diseases (Blood Diseases)
02/2008
1Vitreous Hemorrhage
08/2006
1Retinal Detachment (Retinal Detachments)
08/2006

Drug/Important Bio-Agent (IBA)

16Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2021 - 05/2003
15Matrix Metalloproteinases (MMPs)IBA
01/2021 - 06/2003
7ChemokinesIBA
06/2014 - 04/2008
6Peptide Hydrolases (Proteases)FDA Link
01/2019 - 04/2006
5Proteins (Proteins, Gene)FDA Link
05/2020 - 04/2006
4oxyamylose (COAM)IBA
01/2014 - 10/2008
3GelatinasesIBA
01/2021 - 01/2016
3GelatinIBA
01/2021 - 11/2016
3AutoantigensIBA
01/2019 - 06/2009
3Antiviral Agents (Antivirals)IBA
08/2012 - 10/2008
2InterferonsIBA
11/2020 - 06/2003
2Biomarkers (Surrogate Marker)IBA
02/2020 - 11/2018
2LipopolysaccharidesIBA
01/2020 - 10/2017
2Complement System Proteins (Complement)IBA
01/2019 - 10/2012
2Tiopronin (Thiola)FDA Link
01/2019 - 12/2012
2pro-matrix metalloproteinase 9IBA
01/2019 - 11/2016
2AutoantibodiesIBA
01/2019 - 05/2011
2Antigen-Antibody Complex (Immune Complex)IBA
01/2019 - 01/2019
2Tissue Inhibitor of Metalloproteinase-1IBA
10/2017 - 11/2016
2Minocycline (Cyclops)FDA LinkGeneric
01/2017 - 06/2003
2Streptozocin (Streptozotocin)FDA Link
11/2014 - 12/2004
2GlycosaminoglycansIBA
01/2014 - 08/2012
2Biological ProductsIBA
12/2012 - 07/2009
2Matrix Metalloproteinase InhibitorsIBA
05/2011 - 06/2003
2CytokinesIBA
04/2006 - 03/2006
2Insulin (Novolin)FDA Link
12/2004 - 05/2003
1Carmine (Natural Red 4)IBA
10/2022
1Sepharose (Agarose)IBA
01/2021
1Adalimumab (Humira)FDA Link
02/2020
1Infliximab (Remicade)FDA Link
02/2020
1AntigensIBA
01/2019
1Edetic Acid (EDTA)FDA Link
01/2019
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2019
1EpitopesIBA
11/2018
1EndotoxinsIBA
10/2017
1Proteasome InhibitorsIBA
01/2017
1Bortezomib (Velcade)FDA Link
01/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1Azithromycin (Zithromax)FDA LinkGeneric
01/2017
1Dextrans (Dextran)FDA Link
11/2016
1SodiumIBA
11/2016
1ImmunosorbentsIBA
01/2016
1EnzymesIBA
01/2016
1AC133 AntigenIBA
11/2014
1ZincIBA
12/2012
1Metalloproteases (Metalloproteinases)IBA
12/2012
1astacinIBA
12/2012
1hemozoinIBA
05/2012
1Polysaccharides (Glycans)IBA
11/2010
1PolymersIBA
11/2010
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
09/2008
1CAP1-6DIBA
09/2008
1Hemoglobins (Hemoglobin)IBA
08/2006

Therapy/Procedure

4Therapeutics
11/2020 - 06/2003
1Oral Administration
11/2016
1Investigational Therapies (Experimental Therapy)
10/2012
1Drug Therapy (Chemotherapy)
09/2008
1Radiotherapy
09/2008